We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SCPS market cap is 3.55M. The company's latest EPS is USD -0.5504 and P/E is -0.31.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.32M | -1.9M | -1.84M | -2.68M | -2.93M |
| Net Income | -3.32M | -1.9M | -1.73M | -2.45M | -2.62M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -2.69M | -10.16M | -27.63M | -11.72M |
| Net Income | -2.69M | -10.86M | -26.95M | -11.61M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 1.67M | 416k | 392k | 1.6M | 498k |
| Total Liabilities | 5.37M | 5.92M | 7.45M | 9.31M | 11M |
| Total Equity | -3.7M | -5.5M | -7.06M | -7.71M | -10.5M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 772k | 1.97M | 8.19M | 392k |
| Total Liabilities | 855k | 3.81M | 4.17M | 7.45M |
| Total Equity | -83k | -1.83M | 4.02M | -7.06M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -6.85M | -7.71M | -8.13M | -760k | -1.77M |
| Investing | -2k | -1,000 | -2k | N/A | N/A |
| Financing | N/A | N/A | 242k | 2.02M | 1.97M |
| Year End December 30 2022 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.12M | -2.53M | -11.42M | -8.13M |
| Investing | -4k | N/A | -2k | -2k |
| Financing | 2.18M | 4.35M | 17.56M | 242k |
| Market Cap | 3.55M |
| Price to Earnings Ratio | -0.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 28.81 |
| Price to Book Ratio | -0.51 |
| Dividend Yield | - |
| Shares Outstanding | 21.09M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (4.24%) |
| Company Name | Scopus BioPharma Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.scopusbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
